The moderate Ki-67 (60%) and scattered c-Myc positivity indicate a somewhat aggressive clinical course, but the absence of strong MYC positivity and CD5 negativity may suggest a more favorable prognosis than double-hit or highly proliferative lymphomas. This evidence concerns the gene CD5 and lymphoma.